Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
Raut A, Chopra S, Mittal P, Patil G, Mahantshetty U, Gurram L, Swamidas J, Ghosh J, Gulia S, Popat P, Deodhar K, Maheshwari A, Gupta S. Raut A, et al. Among authors: swamidas j. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1248-1256. doi: 10.1016/j.ijrobp.2020.07.020. Epub 2020 Jul 15. Int J Radiat Oncol Biol Phys. 2020. PMID: 32681859
Magnetic resonance image-based dose volume parameters and clinical outcome with high dose rate brachytherapy in cervical cancers--a validation of GYN GEC-ESTRO brachytherapy recommendations.
Mahantshetty U, Swamidas J, Khanna N, Engineer R, Merchant NH, Shrivastava S. Mahantshetty U, et al. Among authors: swamidas j. Clin Oncol (R Coll Radiol). 2011 Jun;23(5):376-7. doi: 10.1016/j.clon.2011.02.006. Epub 2011 Mar 5. Clin Oncol (R Coll Radiol). 2011. PMID: 21377847 No abstract available.
Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
Mahantshetty U, Swamidas J, Khanna N, Engineer R, Merchant NH, Deshpande DD, Shrivastava S. Mahantshetty U, et al. Among authors: swamidas j. Int J Gynecol Cancer. 2011 Aug;21(6):1110-6. doi: 10.1097/IGC.0b013e31821caa55. Int J Gynecol Cancer. 2011. PMID: 21633296
Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicity.
Chopra S, Dora T, Engineer R, Mechanery S, Agarwal P, Kannan S, Ghadi Y, Swamidas J, Mahantshetty U, Shrivastava SK. Chopra S, et al. Among authors: swamidas j. Brachytherapy. 2015 Nov-Dec;14(6):881-8. doi: 10.1016/j.brachy.2015.08.007. Epub 2015 Sep 26. Brachytherapy. 2015. PMID: 26409708
56 results